Resistencia bacteriana en diarrea y aceite esencial de arbol de té como potencial tratamiento: revisión
DOI:
https://doi.org/10.18633/biotecnia.v26.2270Palabras clave:
Diarrea, Antibióticos, Resistente a los antibióticos, Aceites esenciales, Árbol de TéResumen
La diarrea bacteriana es un problema de salud pública mundial, especialmente en países en desarrollo como México, donde persisten altas tasas de morbilidad y mortalidad, sobre todo en niños menores de cinco años. Aunque los antibióticos como la ciprofloxacina, ceftriaxona y azitromicina son efectivos, el aumento de la resistencia bacteriana nos ha forzado a buscar alternativas. El aceite esencial de árbol de té (TTEO) ha sido propuesto como tratamiento potencial, pero la investigación, especialmente in vivo, es limitada debido a la variabilidad en la composición del aceite y la falta de protocolos estandarizados.
Esta revisión recopila datos actuales (2000-2024) sobre la epidemiología, diagnóstico, tratamiento y resistencia a antibióticos de bacterias clave que causan diarrea (E. coli, Shigella spp., Campylobacter spp. y Salmonella spp.), y evalúa el potencial antibacteriano del TTEO. Los estudios in vitro muestran sus efectos bactericidas y bacteriostáticos, mientras que los estudios in vivo evalúan su impacto terapéutico en modelos animales. En conclusión, el TTEO tiene potencial como una alternativa o complemento a los antibióticos para tratar la diarrea bacteriana, pero se necesitan más estudios in vivo para confirmar su eficacia y optimizar su aplicación en la práctica clínica.
Descargas
Citas
Aghraz, A., Benameur, Q., Gervasi, T., Ait Dra, L., Ben-Mahdi, M., Larhsini, M., Markouk, M., y Cicero, N. 2018. Antibacterial activity of Cladanthus arabicus and Bubonium imbricatum essential oils alone and in combination with conventional antibiotics against Enterobacteriaceae isolates. Letters in Applied Microbiology. 67: 175–182.
Aziz, Z.A.A., Ahmad, A., Setapar, S.H.M., Karakucuk, A., Azim, M.M., Lokhat, D., Rafatullah, M., Ganash, M., Kamal, M.A., y Ashraf, G. 2018. Essential Oils: Extraction Techniques, Pharmaceutical and Therapeutic potential. Current Drug Metabolism. 19: 1100–1110.
Baker, S., y Chung-The, H. 2018. Recent insights into Shigella. Current Opinion in Infectious Diseases, 31, 449–454.
Bakkali, F., Averbeck, S., Averbeck, D., y Idaomar, M. 2008. Biological effects of essential oils: A review. Food and Chemical Toxicology. 46, 446–475.
Barrantes-Jiménez, K., y Achí-Araya, R. 2009. Interacciones celulares en el proceso de invasión de Shigella sp. Revista Panamericana de Infectología. 11: 56–61.
Bouarab-Chibane, L., Degraeve, P., Ferhout, H., Bouajila, J., y Oulahal, N. 2019. Plant antimicrobial polyphenols as potential natural food preservatives. Journal of the Science of Food and Agriculture. 99: 1457–1474.
Bowen, A. 2018. Shigellosis: En: In Yellow Book 2018: Health Information for International Travel. G. Brunette (Ed.), pp. 319-320. Oxford University Press, U.K.
Bučková, M., Puškárová, A., Kalászová, V., Kisová, Z., y Pangallo, D. 2018. Essential oils against multidrug resistant gram-negative bacteria. Biologia. 73: 803-808.
Calo, J.R., Crandall, P.G., O’Bryan, C.A., y Ricke, S.C. 2015. Essential oils as antimicrobials in food systems—A review. Food Control. 54: 111–119.
Campoli-Richards, D.M., Monk, J.P., Price, A., Benfield, P., Todd, P.A., y Ward, A. 1988. Ciprofloxacin. Drugs. 35: 373–447.
Carson, C.F., y Riley, T.V. 1995. Toxicity of the essential oil of Melaleuca alternifolia or tea tree oil. Journal of Toxicology and Clinical Toxicology. 33(2): 193-194.
Carson, C.F., Hammer, K.A., y Riley, T.V. 2006. Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties. Clinical Microbiology Reviews. 19: 50–62.
CDC. Campylobacter (Campylobacteriosis). [Consultado 13 mayo 2023] 2023a. Disponible en: https://www.cdc.gov/campylobacter/faq.html
CDC. E. coli (Escherichia coli). [Consultado 13 mayo 2023] 2023b. Disponible en: https://www.cdc.gov/ecoli/index.html
CDC. La resistencia a los antibióticos, los alimentos y los animales de producción. [Consultado 13 de mayo 2023] 2023c. Disponible en: https://www.cdc.gov/foodsafety/es/challenges/antibiotic-resistance.html
CDC. Salmonella: Diagnostic and Public Health Testing. [Consultado 13 de mayo de 2023] 2019. Disponible en: https://www.cdc.gov/salmonella/general/diagnosis-treatment.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fsalmonella%2Fgeneral%2Fdiagnosis.html
CDC. Shigella-Shigellosis. [Consultado 13 de mayo de 2023] 2023c. Disponible en: https://www.cdc.gov/shigella/prevention-control.html.
Chouhan, S., Sharma, K., y Guleria, S. 2017. Antimicrobial activity of some essential oils—Present status and future perspectives. Medicines. 4(3): 58.
Cohen, R., Raymond, J., y Gendrel, D. 2017. Antimicrobial treatment of diarrhea/acute gastroenteritis in children. Archives de Pédiatrie. 24: 26–29.
Dagli, N., Dagli, R., Mahmoud, R.S., y Baroudi, K. 2015. Essential oils, their therapeutic properties, and implication in dentistry: A review. Journal of International Society of Preventive & Community Dentistry. 5: 335–340.
Dasti, J.I., Tareen, A.M., Lugert, R., Zautner, A.E., y Groß, U. 2010. Campylobacter jejuni: A brief overview on pathogenicity-associated factors and disease-mediating mechanisms. International Journal of Medical Microbiology. 300: 205–211.
Denamur, E., Clermont, O., Bonacorsi, S., y Gordon, D. 2021. The population genetics of pathogenic Escherichia coli. Nature Reviews Microbiology. 19: 37–54.
Dhifi, W., Bellili, S., Jazi, S., Bahloul, N., y Mnif, W. 2016. Essential Oils' Chemical Characterization and Investigation of Some Biological Activities: A Critical Review. Medicines. 3: 1–16.
Eltai, N.O., Yassune, H.M., Al-Thani, M.A., Ismail, A., Ibrahim, E., y Alali, W.Q. 2018. Prevalence of antibiotic resistant Escherichia coli isolates from fecal samples of food handlers in Qatar. Antimicrobial Resistance and Infection Control. 7: 1–7.
Fagundes-Neto, U., y Affonso-Scaletsky, I. 2000. Escherichia coli infections and malnutrition. The Lancet. 356(27).
FDA. Nutrición e infección, salud y enfermedad. [Consultado 13 de mayo de 2023] 2023. Disponible en: http://www.fao.org/3/w0073s/w0073s07.htm
Fernández, H. 2011. Campylobacter y Campylobacteriosis: Una mirada desde América del Sur. Revista Peruana de Medicina Experimental y Salud Pública. 28: 121–127.
Firmino, J.P., Vallejos-Vidal, E., Sarasquete, Ortiz-Delgado, J.B., Balasch, J.C., Tort, L., Estevez, A., Reyez-López, F.E., y Gisbert, E. 2020. Unveiling the effect of dietary essential oils supplementation in Sparus aurata gills and its efficiency against the infestation by Sparicotyle chrysophrii. Scientific reports. 10(1):17764.
Foley, S. 2012. Campylobacter jejuni. En: Bad Bug Book: Foodborne Pathogenic Microorganisms and Natural Toxins Handbook. K.A. Lampel (Ed.), pp. 14–17. FDA, Atlanta.
Gavanji, S., Sayedipour, S.S., Larki, B., y Bakhtari, A. 2015. Antiviral activity of some plant oils against herpes simplex virus type 1 in Vero cell culture. Journal of Acute Medicine. 5: 62–68.
Geissler, A.L., Mahon, B.E., y Fitzgerald, C. 2018. Campylobacteriosis. En: Yellow Book 2018: Health Information for International Travel. G. Brunette (Ed.), pp. 149-150. Oxford University, New York.
Gomes, T.A., Elias, W.P., Scaletsky, I.C., Guth, B.E., Rodrigues, J.F., Piazza, R.M., Ferreira, L.C., y Martinez, M.B. 2016. Diarrheagenic Escherichia coli. Brazilian Journal of Microbiology. 47: 3–30.
Groot, A.C., y Schmidt, E. 2006. Tea tree oil: Contact allergy and chemical composition. Contact Dermatitis. 75: 128–143.
Hammack, T. 2012. Salmonella species. En: Bad Bug Book: Foodborne Pathogenic Microorganisms and Natural Toxins Handbook. K.A. Lampel (Ed.) pp. 9–13. FDA, Atlanta.
Harkenthal, M., Reichling, J., Geiss, H.K., y Saller, R. 1999. Comparative study on the in vitro antibacterial activity of Australian tea tree oil, cajuput oil, niaouli oil, manuka oil, kanuka oil, and eucalyptus oil. Pharmazie. 54: 462–463.
Hebblestrup-Jensen, B., Olsen, K.E., Struve, C., y Krogfelt, K.A. 2014. Epidemiology and Clinical Manifestations of Enteroaggregative Escherichia coli. Clinical Microbiology Reviews. 27: 614–630.
Hirose, K., y Sato, E. 2011. Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea. Hearing Research. 272: 108–116.
Hunter, J.C., y Francois-Watkins, L.K. 2018. Salmonella (Nontyphoidal). En: Yellow Book 2018: Health Information for International Travel. G. Brunette (Ed.), pp. 304–306. Oxford University Press, New York.
Hussen, S., Mulatu, G., y Kassa, Z.Y. 2019. Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 18: 1–11.
Jajere, S.M. 2019. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Veterinary World. 12: 504-521.
Kabir-Mumu, S., y Mahboob-Hossain, M. 2018. Antimicrobial Activity of Tea Tree oil Against Pathogenic Bacteria and Comparison its Effectiveness with Eucalyptus Oil, Lemongrass Oil and Conventional Antibiotics. American Journal of Microbiology Research. 6: 73-78.
Kon, K.V., y Rai, M.K. 2012. Plant essential oils and their constituents in coping with multi-drug-resistant bacteria. Expert Review of Anti-infective Therapy. 10: 775–790.
Kurekci, C., Padmanabha, J., Bishop-Hurley, S.L., Hassan, E., Al-Jassim, R.A., y McSweeney, C.S. 2013. Antimicrobial activity of essential oils and five terpenoid compounds against Campylobacter jejuni in pure and mixed culture experiments. International Journal of Food Microbiology. 166: 450-457.
Lamb, H.M., Ormrod, D., Scott, L.J., y Figgit, D.P. 2002. Ceftriaxone: An Update of its Use in the Management of Community-Acquired and Nosocomial Infections. Drugs. 62: 1041-1089.
Lampel, K.A. 2012. Shigella Species. En: Bad Bug Book: Foodborne Pathogenic Microorganisms and Natural Toxins Handbook. K.A. Lampel (Ed.), pp. 22–25. FDA, Atlanta.
Li Dong, Jun Liu, Zhaoxin Zhong, Shunan Wang, Hongrong Wang, Yongjiu Huo, Zhenwu Wei, Lihuai Yu, (2019). Dietary tea tree oil supplementation improves the intestinal mucosal immunity of weanling piglets. Animal Feed Science and Technology. 255: 114209.
Loose, M., Pilger, E., y Wagenlehner, F. (2020). Anti-Bacterial Effects of Essential Oils against Uropathogenic Bacteria. Antibiotics. 9: 1-8.
Lv, X., Chen, L., Zhou, C., Guo, Y., Zhang, G., Kang, J. y Liu, Z. 2022. Dietary tea tree (Melaleuca alternifolia) oil supplementation enhances the expressions of amino acid transporters in goat ileal mucosa and improves intestinal immunity. Food Science & Nutrition. 10(11): 3749-3758.
Mahmoud M., Abo Ghanima, Ayman A. Swelum, Mustafa Shukry, Safinaz A. Ibrahim, Mohamed E. Abd El-Hack, Asmaa F. Khafaga, Ahmad R. Alhimaidi, Aiman A. Ammari, Khaled A. El-Tarabily, Mona E.M. y Younis, M.E. 2021. Impacts of tea tree or lemongrass essential oils supplementation on growth, immunity, carcass traits, and blood biochemical parameters of broilers reared under different stocking densities. Poultry Science, 100(11):101443.
Miguel, M.G. (2010). Antioxidant and anti-inflammatory activities of essential oils: A short review. Molecules. 15: 9252–9287.
Morales-Cruz, V.G., y Huerta-Romano, J.F. 2010. Escherichia coli diarreogénica. Conocimientos vigentes. Revista Mexicana de Pediatría. 77: 271-276.
Newell, D.G., y La Ragione, R.M. (2017). Enterohaemorrhagic and other Shiga toxin-producing Escherichia coli (STEC): Where are we now regarding diagnostics and control strategies? Transboundary and Emerging Diseases. 65: 49-71.
O´Reilly, C.E., Iwamoto, M., y Griffin, P.M. 2018. Escherichia coli, Diarrheagenic. En: Yellow Book 2018: Health Information for International Travel. G. Brunette (Ed.), pp. 174–177. Oxford University Press, New York.
Ojkic, N., Lilja, E., Direito, S., Dawson, A., Allen, R.J., y Waclaw, B. 2020. A Roadblock-and-Kill Mechanism of Action Model for the DNA-Targeting Antibiotic Ciprofloxacin. Antimicrobial Agents and Chemotherapy. 64: 1-17.
Parnham, M.J., Haber, V.E., Giamerellos-Bourboulis, E.J., Perletti, G., Verleden, G.M., y Vos, R. 2014. Azithromycin: Mechanisms of action and their relevance for clinical applications. Pharmacology y Therapeutics. 143: 225-245.
Perricone, M., Arace, E., Corbo, M.R., Sinigaglia, M., y Bevilacqua, A. 2015. Bioactivity of essential oils: a review on their interaction with food components. Frontiers in Microbiology. 6: 1-7.
Puzari, M., Sharma, M., y Chetia, P. 2018. Emergence of antibiotic resistant Shigella species: A matter of concern. Journal of Infection and Public Health. 11: 451-454.
Qu, H., Cheng, Y., Chen, Y., Zhao, Y., Li, J., Wen, C., y Zhou, Y. 2019. Dietary Tea Tree (Melaleuca alternifolia) Oil Supplementation Improves Growth Performance, Cecal Microflora, Immunity, and Antioxidant Capacity of Partridge Shank Chickens. Journal of Poultry Science. 56(3): 212-219.
Rios-Muñiz, D., Cerna-Cortés, J.F., Morán-García, N., Meza-Segura, M., y Estrada-García, T. 2019. Escherichia coli enterotoxigénica y enteroagregativa: prevalencia, patogénesis y modelos muridos. Gaceta Médica de México. 155: 410-416.
Schleibinger, M., Steinbach, C.L., Topper, C., Kratzer, A., Liebchen, U. y Kees, F. 2015. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients. British Journal of Clinical Pharmacology. 80: 525–533.
Shane, A.L., Mody, R.K., Crump, J.A., Tarr, P.I., Steiner, T.S., Kotloff, K. y Pickering, L.K. 2017. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clinical Infectious Diseases. 65: 45-80.
Shu-Kee, E., Pusparajah, P., Nurul-Syakima, A.M., Hooi-Leng, S., Kok-Gan, C., y Learn-Han, L. 2015. Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance. Frontiers in Life Science. 8: 284-293.
Singh, I.R., y Pulikkal, A.K. 2022. Preparation, stability and biological activity of essential oil-based nanoemulsions: A comprehensive review. OpenNano. 8: 100066.
Swamy, M.K., Akhtar, M.S., y Sinniah, U.R. 2016. Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review. Evidence-Based Complementary and Alternative Medicine. 2016: 1–21.
Tarr, G.A., Oltean, H.N., Phipps, A.I., Rabinowitz, P., y Tarr, P.I. 2018. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition. International Journal of Medical Biology. 308: 921-926.
van den Bogaard, A.E., & Stobberingh, E.E. 2000. Epidemiology of resistance to antibiotics: Links between animals and humans. International Journal of Antimicrobial Agents. 14: 327–335.
Vidal, J., Canizález-Román, A., Futiérrez-Jiménez, J., y Navarro-García, F. 2007. Patogénesis molecular, epidemiología y diagnóstico de Escherichia coli enteropatógena. Salud Pública de México. 49: 376-386.
Wang, L., Zhang, Y., Liu, L., Huang, F., y Dong, B. 2021. Effects of Three-Layer Encapsulated Tea Tree Oil on Growth Performance, Antioxidant Capacity, and Intestinal Microbiota of Weaned Pigs. Frontiers in Veterinary Science. 8: 789225.
Wei, S., Zhao, X., Yu, J., Yin, S., Liu, M., Bo, R., y Li, J. 2021. Characterization of tea tree oil nanoemulsion and its acute and subchronic toxicity. Regulatory Toxicology and Pharmacology, 124: 104999.
WHO. Enfermedades diarreicas. [Consultado 14 de mayo de 2023] 2017. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/diarrhoeal-disease.
WHO. Salmonella (no tifoidea). [Consultado 14 de mayo de 2023] 2018. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/salmonella-(non-typhoidal).
WHO. Campylobacter. [Consultado 14 de mayo de 2023] 2020. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/campylobacter.
WHO. Resistencia a los antibióticos. [Consultado 14 de mayo de 2023]2020b. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/resistencia-a-los-antibi%C3%B3ticos.
Wu, L.J., Luo, Y., Shi, G.I., y Li, Z.Y. 2021. Prevalence, Clinical Characteristics and Changes of Antibiotic Resistance in Children with Nontyphoidal Salmonella Infections from 2009–2018 in Chongqing, China. Infectious Drug Resistance. 14: 1403-1413.
Xiang, Y., Wu, F., Chai, Y., Xu, X., Yang, L., Tian, S., Zhang, H., Li, Y., Yang, C., Liu, H., Qiu, S., Song, H., y Sun, Y. 2020. A new plasmid carrying mphA causes prevalence of azithromycin resistance in enterotoxigenic Escherichia coli serogroup O6. BMC Microbiology. 20: 1-9.
Yadav, E., Kumar, S., Mahant, S., Khatkar, S., y Rao, R. 2016. Tea tree oil: a promising essential oil. Journal of Essential Oil Research. 29: 1-13.
Yang, C., Zhang, L., Cao, G., Feng, J., Yue, M., Xu, Y., Dai, B., Han, Q., y Guo, X. 2019. Effects of dietary supplementation with essential oils and organic acids on the growth performance, immune system, fecal volatile fatty acids, and microflora community in weaned piglets. Journal of Animal Science. 97: 133–143.
Young, K.T., Davis, L.M., y DiRita, V.J. 2007. Campylobacter jejuni: Molecular biology and pathogenesis. Nature Reviews Microbiology. 5: 665-679.
Descargas
Archivos adicionales
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
La revista Biotecnia se encuentra bajo la licencia Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)